Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Niloufar Sadat Nourbakhsh"'
Autor:
Samira Nomiri, Hassan Karami, Behzad Baradaran, Darya Javadrashid, Afshin Derakhshani, Niloufar Sadat Nourbakhsh, Mahdi Abdoli Shadbad, Antonio Giovanni Solimando, Neda Jalili Tabrizi, Oronzo Brunetti, Saeed Nasseri, Vito Racanelli, Hossein Safarpour, Nicola Silvestris
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 146, Iss , Pp 112537- (2022)
Background: Ovarian cancer (OC) is one of the worrisome gynecological cancers worldwide. Given its considerable mortality rate, it is necessary to investigate its oncogenesis. Methods: In this study, we used systems biology approaches to describe the
Externí odkaz:
https://doaj.org/article/c625561bc102406eb960f1f007510698
Autor:
Afshin Derakhshani, Zeinab Rostami, Hossein Safarpour, Mahdi Abdoli Shadbad, Niloufar Sadat Nourbakhsh, Antonella Argentiero, Sina Taefehshokr, Neda Jalili Tabrizi, Omid Kooshkaki, Reza Vaezi Astamal, Pankaj Kumar Singh, Nima Taefehshokr, Nazila Alizadeh, Nicola Silvestris, Behzad Baradaran
Publikováno v:
Molecules, Vol 26, Iss 8, p 2278 (2021)
Over the past decade, there have been remarkable advances in understanding the signaling pathways involved in cancer development. It is well-established that cancer is caused by the dysregulation of cellular pathways involved in proliferation, cell c
Externí odkaz:
https://doaj.org/article/a7e22f4340a942d8a56ebeb58e4e141d
Autor:
Afshin Derakhshani, Nicola Silvestris, Nima Hemmat, Zahra Asadzadeh, Mahdi Abdoli Shadbad, Niloufar Sadat Nourbakhsh, Leila Mobasheri, Parviz Vahedi, Morteza Shahmirzaie, Oronzo Brunetti, Hossein Safarpour, Behzad Baradaran
Publikováno v:
Molecules, Vol 25, Iss 21, p 5148 (2020)
Since the current treatments have not resulted in the desired outcomes for melanoma patients, there is a need to identify more effective medications. Together with other snake venom proteins, cytotoxin-II has shown promising results in tumoral cells.
Externí odkaz:
https://doaj.org/article/998198c9dca144cbbca9878bbf1732cc
Autor:
Ziba Lotfi, Amir Baghbanzadeh, Niloufar Sadat Nourbakhsh, Darya Javadrashid, Nima Hemmat, Khalil Hajiasgharzadeh, Behzad Baradaran
Publikováno v:
Immunology Letters. 232:48-59
Pancreatic ductal adenocarcinoma has a poor 5-year survival rate that makes it one of the most fatal human malignancies. Unfortunately, despite the serious improvement in the survival of most cancers, there has been a minor advance in pancreatic canc
Autor:
Samira Nomiri, Hassan Karami, Behzad Baradaran, Darya Javadrashid, Afshin Derakhshani, Niloufar Sadat Nourbakhsh, Mahdi Abdoli Shadbad, Antonio Giovanni Solimando, Neda Jalili Tabrizi, Oronzo Brunetti, Saeed Nasseri, Vito Racanelli, Hossein Safarpour, Nicola Silvestris
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 146, Iss, Pp 112537-(2022)
Background: Ovarian cancer (OC) is one of the worrisome gynecological cancers worldwide. Given its considerable mortality rate, it is necessary to investigate its oncogenesis. Methods: In this study, we used systems biology approaches to describe the
Autor:
Nicola Silvestris, Zeinab Rostami, Hossein Safarpour, Reza Vaezi Astamal, Nazila Alizadeh, Neda Jalili Tabrizi, Omid Kooshkaki, Mahdi Abdoli Shadbad, Antonella Argentiero, Niloufar Sadat Nourbakhsh, Nima Taefehshokr, Afshin Derakhshani, Pankaj Singh, Behzad Baradaran, Sina Taefehshokr
Publikováno v:
Molecules, Vol 26, Iss 2278, p 2278 (2021)
Molecules
Molecules
Over the past decade, there have been remarkable advances in understanding the signaling pathways involved in cancer development. It is well-established that cancer is caused by the dysregulation of cellular pathways involved in proliferation, cell c
Autor:
Nicola Silvestris, Behzad Baradaran, Leila Mobasheri, Niloufar Sadat Nourbakhsh, Oronzo Brunetti, Mahdi Abdoli Shadbad, Nima Hemmat, Parviz Vahedi, Zahra Asadzadeh, Afshin Derakhshani, Hossein Safarpour, Morteza Shahmirzaie
Publikováno v:
Molecules
Molecules, Vol 25, Iss 5148, p 5148 (2020)
Volume 25
Issue 21
Molecules, Vol 25, Iss 5148, p 5148 (2020)
Volume 25
Issue 21
Since the current treatments have not resulted in the desired outcomes for melanoma patients, there is a need to identify more effective medications. Together with other snake venom proteins, cytotoxin-II has shown promising results in tumoral cells.